This COVID-19 vaccine could be ‘ready for use’ by end of year


Moderna?s vaccine against COVID-19 could be ready for widespread use by the end of this year, U.S. and company officials said on Monday, after the drugmaker announced the start of a 30,000-subject trial to demonstrate it is safe and effective, the final hurdle prior to regulatory approval. The trial is the first such late-stage study under the Trump administration’s program to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.